Preethi Sundaram
Chief Tech/Sci/R&D Officer chez SANOFI
Fortune : 407 124 $ au 31/03/2024
Profil
Preethi Sundaram is currently the Director-Global Clinical Research at Sanofi and the Chief Strategy Officer at Catalyst Pharmaceuticals, Inc. She has a background in undergraduate studies from the University of Madras and Birla Institute of Technology & Science.
She also holds an MBA from London Business School and a doctorate from the University of Anglia Ruskin.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
28/03/2024 | 25 541 ( 0,02% ) | 407 124 $ | 31/03/2024 |
Postes actifs de Preethi Sundaram
Sociétés | Poste | Début |
---|---|---|
CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06/07/2021 |
SANOFI | Chief Tech/Sci/R&D Officer | - |
Formation de Preethi Sundaram
Birla Institute of Technology & Science | Undergraduate Degree |
University of Madras | Undergraduate Degree |
London Business School | Masters Business Admin |
University of Anglia Ruskin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SANOFI | Health Technology |
Entreprise privées | 1 |
---|---|
Catalyst Pharmaceuticals, Inc. |